Nautilus Biotechnology, Inc.
Status: Publicly traded
Direct answer
Nautilus Biotechnology, Inc. is publicly traded on NASDAQ under the ticker NAUT.
Nautilus Biotechnology, Inc. is an emerging life sciences firm dedicated to pioneering a platform technology aimed at quantifying and comprehensively understanding the intricate complexities of the proteome. Their flagship offering, the Nautilus Platform, is an integrated proteomics system. It provides a complete, end-to-end solution, including specialized instruments, essential consumables, and advanced software...
Can you invest in Nautilus Biotechnology, Inc.?
Yes. Nautilus Biotechnology, Inc. trades publicly on NASDAQ as NAUT.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Nautilus Biotechnology, Inc.
Detailed equity research is provided by MarketSnap.